Interested in sharing the research? You can order print copies of many research publications.

Order Reprints

Newsletter Sign-Up

Keep up to date with NPC news and events by signing up for our e-newsletter E.V.I.dently, and our CER Daily Newsfeed.

Subscribe POLICY

Setting Priorities for Comparative Effectiveness Research: From Assessing Public Health Benefits to Being Open With the Public

Abstract (from Health Affairs): Medicine’s current evidence base is insufficient for many of the decisions made daily by clinicians, patients, purchasers, and policy makers. The Patient-Centered Outcomes Research Institute (PCORI) represents an effort by the US government to address this shortcoming by funding comparative effectiveness research (CER). Prioritizing that research will be a critical first step. To better understand components of an optimal process, NPC reviewed the literature and conducted interviews regarding the prioritization efforts of leading public and private health organizations in the United States and abroad. From this review, NPC proposes a framework for prioritization, poses and answers key questions, and makes recommendations regarding application of that framework. NPC also recommends that during the priority-setting process, there should be transparent conversations among those who make decisions about the priorities and the public.

 

View the interview with NPC Chief Science Officer Dr. Robert Dubois and read the press release.

 

About the project:

NPC undertook this research to understand the components of an optimal approach to prioritizing CER. It is especially timely because PCORI is working on its priorities for the CER that it will fund; these priorities will set the tone for all of the institute’s future activities.The research also highlights the difficult questions PCORI will face as the public dialogue on its national research priorities and research agenda begins.

Why prioritization is important:

Not all topics can be studied; there are budget and time constraints that limit what activities can be done. Without setting criteria or defining priorities, one risks including all areas and prioritizing none, an outcome that is not helpful to patients or providers who are looking for answers.

Key recommendations that should be used to make research decision-making processes more effective include:

  • Defining priorities to identify what has greater and lesser importance;
  • Ensuring that all stakeholders are engaged in all aspects of the prioritization process, including identifying topics and prioritizing among them;
  • Using a systematic approach when considering all evidence as it relates to prioritizing topics;
  • Maintaining an open and transparent consensus process which can handle inevitable disagreement;
  • Communicating the process and the results of the process;
  • Allowing for the incorporation of new evidence that takes into account continuing advances in medical care or technology; and
  • Evaluating the results of the process by asking both those involved in the process and the general public. 
Blog Post

#TBT: Senior Citizens Day & Individualized Pharmaceutical Care

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...
Blog Post

CER Tweets of the Week: All Things Patient (August 11-15)

This week’s comparative effectiveness research (CER) tweets revolve around patient-centric news. The Patient-Centered Outcomes Research Institute’s (...
Blog Post

CER Tweets of the Week: Will CER Really Deliver Better Patient Outcomes? (August 4-8)

Comparative effectiveness research (CER) stakeholders shared news about the Patient-Centered Outcomes Research Institute’s next funding round with...
Newsletter Volume

E.V.I.dently July 2014

NPC MessageWhen & How Health Decision-Makers Should Consider Individual Patient DifferencesBy Jennifer S. Graff, PharmD, NPC Director of...
Press Release

NPC Study Outlines When & How Health Decision-Makers Should Consider Individual Patient Differences

Washington, DC (July 29, 2014)—New research led by the National Pharmaceutical Council (NPC) can assist health care stakeholders to understand when...
Press Release

NPC Annual Stakeholder Survey: Comparative Effectiveness Research Is Important, But Impact on Health Care Decision-Making Is Still on the Horizon

(Washington, DC, May 19, 2014)—A new survey of health care stakeholders reveals continued optimism for the use of comparative effectiveness research...
Press Release

CER Collaborative Improving Health Outcomes Through New Comparative Evidence Tools

(Washington, DC, March 24, 2014)—Three peer-reviewed articles published in Value in Health offer important guidance to aid formulary decision-makers...
Press Release

NPC, UMD Study: Factors That Cause Different Treatment Responses Are Not Well Understood or Studied

Washington, DC, November 4, 2013—Although researchers and health care providers widely recognize that individuals with stage IV prostate cancer react...
Commentary and Testimony Page

The State of CER and the Environment for Health Care Decision Making

This month, NPC released its third annual survey on stakeholders’ views on comparative effectiveness research (CER), “The State of Comparative...
Commentary and Testimony Page

Keeping Our Eye on the CER Ball

Until the cherry blossoms begin to bloom later next month, most of the water cooler conversations in Washington will focus on the federal budget....
Commentary and Testimony Page

Leveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?

A growing chorus of voices is publicly sharing data on the effectiveness of treatment options, but one viewpoint has long been shut out of key areas...
Commentary and Testimony Page

Living Up to Its Name? The Role of Patient-Centered Research

Anyone who has ever received bad news from his or her health care provider or held a loved one’s hand when a diagnosis was delivered can understand...
YouTube Videos

Real-World Impact of Comparative Effectiveness Research Findings on Clinical Practice

National Pharmaceutical Council Chief Science Officer Robert W. Dubois, MD, PhD, discusses a peer-reviewed study suggesting that changes are needed...
YouTube Videos

Using Real-World Evidence to Increase Health Care Access, Improve Quality & Reduce Costs

Mitchell Sugarman, vice president of health economics, policy and payment at Medtronic Cardiac and Vascular Group, explains that health care decision...
YouTube Videos

CER and the Environment for Health Care Decision-Making

The National Pharmaceutical Council’s (NPC) fourth annual survey of health care stakeholders is continuing to shed light on the current environment...
YouTube Videos

Webinar: CER Collaborative: Tools You Can Use

Collaborative members hosted a webinar explaining how to use the tools they developed to create greater uniformity and transparency when evaluating...
Blog Post

#TBT: Senior Citizens Day & Individualized Pharmaceutical Care

As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous...
Blog Post

CER Tweets of the Week: All Things Patient (August 11-15)

This week’s comparative effectiveness research (CER) tweets revolve around patient-centric news. The Patient-Centered Outcomes Research Institute’s (...
Blog Post

CER Tweets of the Week: Will CER Really Deliver Better Patient Outcomes? (August 4-8)

Comparative effectiveness research (CER) stakeholders shared news about the Patient-Centered Outcomes Research Institute’s next funding round with...
Blog Post

PCORI Grants, HEOR & FDA Guidance Top CER Tweets of the Week (July 21-25)

What were some of the popular comparative effectiveness research (CER)-related topics on Twitter this week? We saw keen interest in the Patient-...

Research

  •  
  • 1 of 42
  • >

Commentary & Testimony